PharmaSave SRL
PharmaSave reported revenue of 7,800 € for the 2025 financial year (annual accounts filed with the NBB on 14 Sep 2026).
The score of PharmaSave shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +25 % Total assets +79 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
PharmaSave's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Sep 2026
- Year ended 31 Dec 2024filed on 20 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Jul 2022
PharmaSave's financial analysis
- Solvency54.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of PharmaSave
PharmaSave's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0677.769.484
- VAT number
- BE0677769484
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 30 Jun 2017
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 14 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
PharmaSave (SRL) has been based in Antwerp since 2017, active in: retail sale of pharmaceutical products. For 2025, it reports revenue of 7,800 €, a net profit of 667 € and equity of 10,974 €. Its solvency stands at 54.7%, above the median of its sector (44.2%).
Companies similar to PharmaSave
Companies in the same business, of comparable size and area, outside its group.
- Kasibel Retail sale of pharmaceutical products Uccle · balance sheet 20,641 €
- Eklosium Retail sale of pharmaceutical products Schaerbeek · balance sheet 21,432 €
- Apotheek Vandyck Retail sale of pharmaceutical products Anderlecht · balance sheet 21,647 €
- Camille Huby Retail sale of pharmaceutical products Etterbeek · balance sheet 18,562 €
- Ajaga Retail sale of pharmaceutical products Knokke-Heist · balance sheet 21,992 €
- JL Pharma Retail sale of pharmaceutical products Stoumont · balance sheet 22,608 €
- TVB Consult Retail sale of pharmaceutical products Kruisem · balance sheet 17,370 €
- Farmaco Retail sale of pharmaceutical products Ranst · balance sheet 17,325 €
Frequently asked questions about PharmaSave
What is the revenue of PharmaSave?
According to the 2025 annual accounts filed with the NBB, the revenue of PharmaSave amounts to 7,800 €.
What is the VAT number of PharmaSave?
In Belgium, the VAT number is the company number prefixed with BE: BE0677769484 for PharmaSave, if the company is VAT-registered. Its company number (CBE) is 0677.769.484.
Where is the registered office of PharmaSave?
According to the CBE register, the registered office of PharmaSave is in 2610 Antwerp.
What is the equity of PharmaSave?
At the close of the 2025 financial year, the equity of PharmaSave amounts to 10,974 €, a solvency of 54.7% of total assets.
Who manages PharmaSave?
The register lists 1 active mandates at PharmaSave. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of PharmaSave
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →